GTS Securities’s CVS Health CVS Stock Holding History

GTS Securities’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$287K	Sell	3,995 -9,371	-70%	-$722K	0.01%	1129
2025 Q4	$1.06M	Buy	13,366 +6,834	+105%	+$539K	0.04%	423
2025 Q3	$492K	Buy	6,532 +1,751	+37%	+$120K	0.02%	737
2025 Q2	$330K	Sell	4,781 -10,052	-68%	-$659K	0.01%	863
2025 Q1	$1M	Sell	14,833 -2,870	-16%	-$172K	0.04%	390
2024 Q4	$795K	Sell	17,703 -295,423	-94%	-$16.6M	0.04%	432
2024 Q3	$19.7M	Buy	313,126 +49,235	+19%	+$2.87M	0.04%	269
2024 Q2	$15.6M	Buy	263,891 +157,792	+149%	+$9.87M	0.03%	324
2024 Q1	$8.46M	Sell	106,099 -104,268	-50%	-$7.96M	0.02%	587
2023 Q4	$16.6M	Sell	210,367 -5,557	-3%	-$396K	0.03%	395
2023 Q3	$15.1M	Buy	215,924 +95,409	+79%	+$6.76M	0.03%	429
2023 Q2	$8.33M	Buy	+120,515	New	+$8.58M	0.26%	72

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GTS Securities's CVS Position: Q1 2026 in Review

GTS Securities reduced its CVS Health (CVS) stake by 70% in Q1 2026, selling an estimated $722K and leaving 3,995 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #1129.

GTS Securities first reported a position in CVS in Q2 2023 and has held it in 12 quarters since. The position peaked at $19.7M in Q3 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

GTS Securities held 3,995 shares of CVS Health worth $287K as of Q1 2026.
GTS Securities sold 9,371 CVS Health shares in Q1 2026, an estimated $722K.
CVS Health made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1129 holding.
GTS Securities first reported a position in CVS Health in Q2 2023 and has held it in 12 quarters since.
GTS Securities's CVS Health position peaked at $19.7M in Q3 2024.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.